Very pleased to announce TARGET, our new publication in European Urology! ✨

Available open access: sciencedirect.com/science/articl…

🏆 TARGET will also be presented at #EAU24 and I am delighted to announce it has also been awarded Best Abstract by a Resident at #EAU24 ! 🏆

A brief 🧵

1/14

This is the updated #Algorithm for #BladderCancer . Nivo/Gem/Cis was not approved at the time of this discussion w/ Karine Tawagi MD and Sia Daneshmand, M.D. but has been incorporated in this is mage below.

#OncTwitter #MedTwtitter #gusm #MedEd CancerNetwork® #OncEd

Fantastic talk and insights about cutting edge changes in prostate cancer, biopsy technique, and focal therapy from my friend and legend Amir Lebastchi, MD !! Learned a lot. Fun to have you at RutgersCancerInstNJ Rutgers RWJ Urology Saum Ghodoussipour Thomas Jang YUO

The final results of #POUT adjuvant trial in Upper Tract Urothelial cancer (UTUC) adjuvant trial are now published in Journal of Clinical Oncology. This is a landmark study in the field and 💙alison birtle + team should be celebrated.

5-year DFS (1EP): 62% vs. 45%, HR 0.55 (95% CI, 0.38-0.80,…

Online now: Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer dlvr.it/T2NZ6V

Our collaborative review on LND in GU cancers; tremendous effort by Amanda Myers MD Anderson Cancer Center #OncSurgery European Urology Oncology

Open Access link: authors.elsevier.com/a/1i6Q09Cfv-xp…

Alberto Briganti B.C. Leibovich MD #SethLerner Marco Moschini Morgan Roupret Shahrokh F. Shariat Philippe spiess @Astenzl…

Remember how unnecessarily expensive medical school was? When we had to buy all of that medical school equipment including otoscopes, ophalmoscopes, neurology stuff. We had to buy this with loan money. The only thing we needed was a stethacope.

Explaining to Homeland Security why I was yelling “OPEN SHOOTER” in the middle of an airport <<<<<<

Results from PREVENT trial. No difference in complications for TP vs TR prostate biopsy, although NO antibiotics used in TP vs targeted ABX in TR. ABX stewardship is important!

So proud to be part of this excellent group, there is more to come!!

Very important data to inform mgmt timeline for pts. Historically, unknown growth rate pushed for urgent surgery. This shows avg growth rate of RCC venous tumor thrombus is ~1 cm per month. Use info accordingly. Thx to all authors but esp to Nimrod Barashi, M.D. and Ippolito Lab

Happy Halloween from Angel and Joe! #GeauxTigers

Make sure to tune in tomorrow, November 1, 2023, during the 3rd hour of TODAY.

You don’t want to miss this engaging segment!

Gemcitabine + cisplatin + anti-PD-1 led to complete response in 43% of patients with muscle-invasive #BladderCancer , which facilitated bladder sparing and was associated with long-term bladder-intact survival. Matt Galsky The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai

nature.com/articles/s4159…

Will close down candidates to interview over next month so feel free to reach out if interested in fellowship. Pgy4s only.

#LSU Baseball recruiting class

👀👀

Love this!! Fun and talented group!

Please join myself with Mohit Gupta Ross Erik Krasnow MD Max Kates Kirsten Greene Nathan M. Shaw Andrea Apolo, M.D. Gerald Andriole, MD Ryan Werntz Lambros Stamatakis and more for two days of urologic oncology knowledge in our nation’s capital!

medstar.cloud-cme.com/course/courseo…

MedStar Health Georgetown Lombardi Georgetown University Urology

Rich Men North of Richmond has been uploaded to all major streaming platforms and will show up there in a few days.

Im still in a state of shock at the outpouring of love I've seen in the comments, messages and emails. I'm working to respond to everyone as quickly as possible.